LOADING
Comparing Procter & Gamble (PG) and AbbVie Inc (ABBV) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PG | ABBV |
|---|---|---|
| Price | $146.60 | $264.52 |
| Change Today | +1.33% | -0.17% |
| Market Cap | $336.9B | $468.2B |
| P/E Ratio | 21.8 | 74.6 |
| Forward P/E | 20.8 | 18.9 |
| PEG Ratio | 4.15 | 0.43 |
| EPS | $6.63 | $3.55 |
| Revenue Growth (YoY) | 1.5% | 10.2% |
| Profit Margin | 18.4% | 9.8% |
| Return on Equity | 30.3% | 62.3% |
| Dividend Yield | 2.98% | 2.61% |
| Beta | 0.38 | 0.28 |
| 52-Week High | $164.77 | $267.47 |
| 52-Week Low | $134.62 | $189.40 |
| Volume | 7.1M | 3.9M |
AbbVie Inc is the larger company by market capitalization. Procter & Gamble trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Procter & Gamble offers a higher dividend yield for income investors. Procter & Gamble has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.